Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on
出版年份 2021 全文链接
标题
Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on
作者
关键词
-
出版物
Cancers
Volume 13, Issue 3, Pages 509
出版商
MDPI AG
发表日期
2021-01-29
DOI
10.3390/cancers13030509
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor
- (2020) Marianne D. Sadar Expert Opinion on Drug Discovery
- First-in-human phase I study of ARV-110, an androgen receptor (AR) PROTAC degrader in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) following enzalutamide (ENZ) and/or abiraterone (ABI).
- (2020) Daniel Peter Petrylak et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential modulation of the androgen receptor for prostate cancer therapy depends on the DNA response element
- (2020) Steven Kregel et al. NUCLEIC ACIDS RESEARCH
- Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes
- (2020) Xinzhe Yu et al. MOLECULAR CELL
- Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants
- (2020) Carmen A. Banuelos et al. Cancers
- Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide
- (2020) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of MTX-23, a Novel PROTAC of Androgen Receptor Splice Variant-7 and Androgen Receptor, on CRPC resistant to Second-Line Antiandrogen Therapy
- (2020) Geun Taek Lee et al. MOLECULAR CANCER THERAPEUTICS
- Alternative (backdoor) androgen production and masculinization in the human fetus
- (2019) Peter J. O’Shaughnessy et al. PLOS BIOLOGY
- ARV-110: An oral androgen receptor PROTAC degrader for prostate cancer.
- (2019) Taavi Neklesa et al. JOURNAL OF CLINICAL ONCOLOGY
- Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
- (2019) Tatsuo Sugawara et al. INTERNATIONAL JOURNAL OF CANCER
- Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial
- (2019) Karim Fizazi et al. LANCET ONCOLOGY
- ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
- (2019) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
- (2019) Ian D. Davis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer
- (2019) Suriyan Ponnusamy et al. CLINICAL CANCER RESEARCH
- Non-canonical dimerization of the androgen receptor and other nuclear receptors: implications for human disease
- (2019) Alba Jiménez-Panizo et al. ENDOCRINE-RELATED CANCER
- A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer
- (2018) Stephanie Guillaumier et al. EUROPEAN UROLOGY
- Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy
- (2018) Nisha M Badders et al. NATURE MEDICINE
- Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
- (2018) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer
- (2018) Howard I. Scher et al. JAMA Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metastatic Prostate Carcinoma from Imperial Rome (1st to 2nd Centuries AD)
- (2018) Simona Minozzi et al. PATHOBIOLOGY
- Diversity of Quaternary Structures Regulates Nuclear Receptor Activities
- (2018) Pablo Fuentes-Prior et al. TRENDS IN BIOCHEMICAL SCIENCES
- Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy
- (2018) Yasuomi Shimizu et al. Journal of Clinical Medicine
- Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9 ® to Suppress Enzalutamide-resistant Prostate Cancer Progression
- (2017) Ronghao Wang et al. EUROPEAN UROLOGY
- Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands
- (2017) Norihito Shibata et al. JOURNAL OF MEDICINAL CHEMISTRY
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- (2017) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted protein degradation by PROTACs
- (2017) Taavi K. Neklesa et al. PHARMACOLOGY & THERAPEUTICS
- Structure of the homodimeric androgen receptor ligand-binding domain
- (2017) Marta Nadal et al. Nature Communications
- Genetically tunable frustration controls allostery in an intrinsically disordered transcription factor
- (2017) Jing Li et al. eLife
- EPI-001, A Compound Active against Castration-Resistant Prostate Cancer, Targets Transactivation Unit 5 of the Androgen Receptor
- (2016) Eva De Mol et al. ACS Chemical Biology
- Backbone 1H, 15N, 13C NMR assignment of the 518–627 fragment of the androgen receptor encompassing N-terminal and DNA binding domains
- (2016) Sandra Meyer et al. Biomolecular NMR Assignments
- Sequence Context Influences the Structure and Aggregation Behavior of a PolyQ Tract
- (2016) Bahareh Eftekharzadeh et al. BIOPHYSICAL JOURNAL
- Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant Prostate Cancer
- (2016) Y. C. Yang et al. CLINICAL CANCER RESEARCH
- Neoadjuvant Enzalutamide Prior to Prostatectomy
- (2016) Bruce Montgomery et al. CLINICAL CANCER RESEARCH
- Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain
- (2016) Carmen A. Banuelos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and Activation
- (2016) Nada Lallous et al. MOLECULAR CANCER THERAPEUTICS
- DNA binding triggers tetramerization of the glucocorticoid receptor in live cells
- (2016) Diego M. Presman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The History of Prostate Cancer From Antiquity: Review of Paleopathological Studies
- (2016) Kamyar Ghabili et al. UROLOGY
- Galeterone for the treatment of advanced prostate cancer: the evidence to date
- (2016) Emmanuel Antonarakis et al. Drug Design Development and Therapy
- Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic Tagging
- (2015) Jeffrey L. Gustafson et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel–prednisone in metastatic castration-resistant prostate cancer
- (2015) Daniel P. Petrylak et al. INVESTIGATIONAL NEW DRUGS
- AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer – results of two parallel first-in-human phase I studies
- (2015) A. Omlin et al. INVESTIGATIONAL NEW DRUGS
- Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer
- (2015) Zhenfei Li et al. NATURE
- Galeterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer xenografts in vivo
- (2015) Andrew K. Kwegyir-Afful et al. Oncotarget
- EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancer
- (2015) Lucas J. Brand et al. Oncotarget
- Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2015) Emmanuel S. Antonarakis et al. JAMA Oncology
- Engineered repressors are potent inhibitors of androgen receptor activity
- (2015) Greg N. Brooke et al. Oncotarget
- Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer
- (2014) Maria Thadani-Mulero et al. CANCER RESEARCH
- Identification of a Potent Antiandrogen that Targets the BF3 Site of the Androgen Receptor and Inhibits Enzalutamide-Resistant Prostate Cancer
- (2014) Ravi S.N. Munuganti et al. CHEMISTRY & BIOLOGY
- Galeterone Prevents Androgen Receptor Binding to Chromatin and Enhances Degradation of Mutant Androgen Receptor
- (2014) Z. Yu et al. CLINICAL CANCER RESEARCH
- Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells
- (2014) William C. Krause et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor
- (2014) Huifang Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy
- (2014) Sarah K. Martin et al. Molecular Oncology
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Androgen receptor uses relaxed response element stringency for selective chromatin binding and transcriptional regulation in vivo
- (2014) Biswajyoti Sahu et al. NUCLEIC ACIDS RESEARCH
- Characterization of Niphatenones that Inhibit Androgen Receptor N-Terminal Domain
- (2014) Carmen A. Banuelos et al. PLoS One
- Ligand-Independent and Tissue-Selective Androgen Receptor Inhibition by Pyrvinium
- (2013) Minyoung Lim et al. ACS Chemical Biology
- Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
- (2013) Vivek K. Arora et al. CELL
- An androgen receptor N-terminal domain antagonist for treating prostate cancer
- (2013) Jae-Kyung Myung et al. JOURNAL OF CLINICAL INVESTIGATION
- Mini-review: Foldosome regulation of androgen receptor action in prostate cancer
- (2013) Laia Querol Cano et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- AZD3514: A Small Molecule That Modulates Androgen Receptor Signaling and Function In Vitro and In Vivo
- (2013) S. A. Loddick et al. MOLECULAR CANCER THERAPEUTICS
- A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509
- (2013) J. D. Joseph et al. Cancer Discovery
- Overcoming mutation-based resistance to antiandrogens with rational drug design
- (2013) Minna D Balbas et al. eLife
- ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
- (2012) N. J. Clegg et al. CANCER RESEARCH
- Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100
- (2012) J. Richards et al. CANCER RESEARCH
- Backdoor pathway for dihydrotestosterone biosynthesis: Implications for normal and abnormal human sex development
- (2012) Maki Fukami et al. DEVELOPMENTAL DYNAMICS
- Allosteric Modulators of Steroid Hormone Receptors: Structural Dynamics and Gene Regulation
- (2012) Raj Kumar et al. ENDOCRINE REVIEWS
- A role for selective androgen response elements in the development of the epididymis and the androgen control of the 5α reductase II gene
- (2012) Stefanie Kerkhofs et al. FASEB JOURNAL
- The androgen receptor gene mutations database: 2012 update
- (2012) Bruce Gottlieb et al. HUMAN MUTATION
- Role of the HSP90-Associated Cochaperone p23 in Enhancing Activity of the Androgen Receptor and Significance for Prostate Cancer
- (2012) Vikash Reebye et al. MOLECULAR ENDOCRINOLOGY
- Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer
- (2011) M. S. Darshan et al. CANCER RESEARCH
- Niphatenones, Glycerol Ethers from the Sponge Niphates digitalis Block Androgen Receptor Transcriptional Activity in Prostate Cancer Cells: Structure Elucidation, Synthesis, and Biological Activity
- (2011) Labros G. Meimetis et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor through Virtual Screening.
- (2011) Nathan A. Lack et al. JOURNAL OF MEDICINAL CHEMISTRY
- A conserved surface on the ligand binding domain of nuclear receptors for allosteric control
- (2011) Víctor Buzón et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Intrinsic disorder in the androgen receptor: identification, characterisation and drugability
- (2011) Iain J. McEwan Molecular BioSystems
- Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
- (2011) Emma Hörnberg et al. PLoS One
- Prostate metastatic bone cancer in an Egyptian Ptolemaic mummy, a proposed radiological diagnosis
- (2011) Carlos Prates et al. International Journal of Paleopathology
- Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
- (2010) Raymond J. Andersen et al. CANCER CELL
- An androgenic steroid delivery vector that imparts activity to a non-conventional platinum(ii) metallo-drug
- (2010) Martin Huxley et al. DALTON TRANSACTIONS
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- History of prostate cancer treatment
- (2009) Seshadri Sriprasad et al. SURGICAL ONCOLOGY-OXFORD
- Structural Characterization of the Native NH2-Terminal Transactivation Domain of the Human Androgen Receptor: A Collapsed Disordered Conformation Underlies Structural Plasticity and Protein-Induced Folding†
- (2008) Derek N. Lavery et al. BIOCHEMISTRY
- Structural basis for the nuclear import of the human androgen receptor
- (2008) M. L. Cutress et al. JOURNAL OF CELL SCIENCE
- Consequences of poly-glutamine repeat length for the conformation and folding of the androgen receptor amino-terminal domain
- (2008) Philippa Davies et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer
- (2008) A Rodriguez-Gonzalez et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started